DHB — Delivra Health Brands Cashflow Statement
0.000.00%
Last trade - 00:00- CA$7.03m
- CA$5.97m
- CA$13.37m
- 45
- 68
- 68
- 65
Annual cashflow statement for Delivra Health Brands, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28.5 | -7.01 | -0.184 | 0.876 | -1.19 |
| Depreciation | |||||
| Non-Cash Items | 18.5 | 1.76 | -0.858 | -1.23 | 0.448 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.25 | -1.31 | -1.38 | -0.198 | -1.28 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -9.65 | -4.44 | -1.09 | 0.756 | -0.754 |
| Capital Expenditures | -0.033 | -0.022 | -0.041 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 12.3 | 1.37 | 2.95 | 0.011 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | 12.3 | 1.35 | 2.91 | 0.011 | 0 |
| Financing Cash Flow Items | 4.49 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.446 | -0.309 | -0.255 | 0.594 | -0.036 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.02 | -3.35 | 1.64 | 1.48 | -0.898 |